Crown Bioscience

MAY 4, 2021

Why are cancer treatments for children lagging behind the latest advancements in clinical oncology? Crown Bioscience Director Mike Batey takes a closer look at pediatric cancer and how recent regulatory changes and additional research focus may deliver new therapies for kids.

Research 52

Research Pharmaceutical Companies Licensing Licensing 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. What Differentiates Mid-Size CROs? To learn more about our end-to-end services, contact us today.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

PPD

AUGUST 16, 2023

At the end of 2022, the PPD clinical research business of Thermo Fisher Scientific surveyed key leadership and staff on the frontline of clinical trial execution across the industry. Respondents shared their perspectives on the successes and challenges of DCTs and hybrid clinical trials.

Clinical Trials 98

Clinical Trials Trials Clinical Research FDA 98

KIF1A

JULY 1, 2023

Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Using similar logic, researchers measured the movement of KIF1A homodimers (a pair of healthy KIF1A motors, or a pair of mutant KIF1A motors).

Small Molecule 98

Small Molecule FDA Approval Disease Pharmaceutical Companies 98

Molecule Blog

MARCH 17, 2023

Moving research from concept to market is like conducting a symphony — there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project. Funding typically comes from a mix of government agencies, venture capitalists (VCs), and pharmaceutical companies.

Engineering 52

Engineering Research Clinical Trials Government 52

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

H1 Blog

DECEMBER 4, 2023

With the help of digital health platforms, researchers have access to vast amounts of data that can be analyzed to identify potential participants from underrepresented communities. This not only increases diversity in clinical trials but also ensures that all segments of the population are represented in drug development.

Clinical Trials 59

Clinical Trials Trials Pharmaceutical Companies Drug Development 59

Olympian Clinical Research

MAY 6, 2021

Here at Olympian Clinical Research, we’re taking huge strides to change that through our very own ongoing, in-house study for patients with depression. . The post Everything You Need To Know About Our TRAIT Depression Study appeared first on Olympian Clinical Research. What Is The TRAIT Depression Study ?

Clinical Trials 52

Clinical Trials Treatment Clinical Research Trials 52

The Pharma Data

JANUARY 12, 2021

a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

PPD

JULY 20, 2023

In clinical research, the role of drug packaging systems cannot be overlooked. Industry guidelines require biopharmaceutical and biotechnology companies to test their pharmaceutical packaging systems, as the systems often experience prolonged and intimate contact with drug products, drug substances and intermediates.

Packaging 52

Packaging Laboratories Pharmaceutical Companies Compliance 52

Conversations in Drug Development Trends

APRIL 15, 2024

As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Pharmaceutical Companies 52

Vial

MAY 22, 2024

Introduction Veeva Systems and Vial CRO ( contract research organization ) represent stakeholders in the clinical research landscape, which play integral roles in the successful execution of clinical trials.

Clinical Trials 52

Clinical Trials Trials Clinical Research Compliance 52

H1 Blog

SEPTEMBER 14, 2023

As pharmaceutical companies turn to CROs (Clinical Research Organizations) for trial design and technology, there are new opportunities emerging with healthcare data intelligence that can help ensure a bright future for the industry and to make trials more effective, efficient and accessible.

Clinical Trials 59

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 59

PPD

AUGUST 14, 2023

Whether for a clinical product, a marketed product or a diverse portfolio of assets, PPD FSP solutions deliver.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research International Production 52

The Pharma Data

JANUARY 24, 2021

MU, headquartered in Philadelphia, Pennsylvania, is a state-of-the-art urologic care center that embraces independent practice, innovation and research to improve patient outcomes. FACOS, Director of Clinical Research for MU stated “We are excited to work with Theralase for the NMIBC clinical study. Laurence H.

Pharmaceutical Companies 52

Pharmaceutical Companies Virus Clinical Research Pharmaceuticals 52

Vial

FEBRUARY 15, 2024

Clinical trials play a crucial role in advancing medical breakthroughs, but effective management is essential to unlock their full potential. Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. over the forecast period (2022-2030).

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

Vial

MAY 15, 2024

Vial | Pros and Cons The unprecedented consequences of the COVID-19 pandemic gave rise to the advent of decentralized clinical trials (DCTs), which are studies that use telemedicine and remote or local healthcare professionals to enable participants to join from different locations.

Clinical Trials 52

Clinical Trials Trials Clinical Research Compliance 52

Alta Sciences

JANUARY 31, 2025

A non-profit organization, STC was founded in 1965 with 15 scientists from Montral-based pharmaceutical companies. It owned the societal name of the Canadian Association for Research on Drug Safety. Their passion and curiosity to expand the boundaries of toxicology research illuminated the room.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

Advarra

JUNE 9, 2022

Optimizing clinical trial access for potential patients is a critical goal for researchers and sponsors. How can we make clinical research more accessible to anyone who wishes to participate? Decentralized clinical trials (DCTs) can meet that need, but they come with some challenges.

Clinical Trials 52

Clinical Trials Trials FDA Pharmaceutical Companies 52

Vial

JUNE 24, 2024

The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery.

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

The Pharma Data

JANUARY 14, 2021

Dr. Dickstein enjoyed 30 years in the pharmaceutical field before retiring in 1998 as the vice president of clinical research for Transcend Therapeutics, Inc. As a seasoned scientist, Dr. Dickstein spent significant time conducting research. Dickstein spent one year as vice president for MetaWorks, Inc.,

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

H1 Blog

JULY 30, 2024

The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

The Pharma Data

JANUARY 4, 2021

Outline of the new company (1) Company name: Meiji Pharma USA Inc. Burr Boulevard, Teaneck, NJ 07666 (3) President: Yasushi Miyazawa (4) Scope of business: Clinical research and development (5) Paid in capital: US$100,000. (2) Location: 500 Frank W.

Pharmaceutical Companies 40

Pharmaceutical Companies Clinical Development Pharmaceuticals Clinical Research 40

The Pharma Data

JUNE 26, 2021

Together with our research partners, BIG conducts landmark, practice-changing trials that can have a significant impact on the lives of women with breast cancer,” sa id David Cameron , Chair of the BIG Executive Board. Adjuvant therapy helps prevent and delay the progression of disease into the later setting.

Clinical Trials 52

Clinical Trials International Trials Therapies 52

The Pharma Data

JANUARY 6, 2021

“Further, PDE4-inhibition is a well-documented pharmacological target for a number of other inflammatory indications, and we look forward to advancing our clinical research to realize the full potential of orismilast for the benefit of the millions of patients living with inflammatory conditions globally,” adds Professor Sommer.

FDA Approval 52

FDA Approval FDA Clinical Development Clinical Research 52

The Pharma Data

MARCH 26, 2021

Global Therapeutic Area Head, Neuroscience, Janssen Research & Development, LLC. This is a significant milestone and an important step forward in our goal to make a positive impact for patients with significant unmet needs and unique societal challenges,” said Bill Martin, Ph.D.,

Treatment 52

Treatment Pharmaceutical Companies Pharmaceuticals FDA Approval 52

H1 Blog

NOVEMBER 29, 2023

Data sharing is crucial for promoting scientific discoveries and informed decision-making in clinical practice. Without access to all the relevant data, researchers are unable to fully understand the complexities of diseases and develop effective treatments.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59

Broad Institute

OCTOBER 3, 2023

Ten years ago, the institute’s Genomics Platform launched a clinical lab, called the Clinical Research Sequencing Platform (CRSP), to offer high-quality molecular tests that can be used in a clinical setting. Q: What is Broad Clinical Labs? Q: Why are you changing the name to Broad Clinical Labs now?

Clinical Trials 52

Clinical Trials Laboratories Science Pharmaceutical Companies 52

Vial

APRIL 18, 2024

The urgency for novel therapeutic approaches makes ophthalmology a rapidly growing domain of clinical research. Market research indicates significant growth in the ophthalmic clinical trials market, driven by increased disease prevalence, demand for ocular treatments, and rising research funding. from 2023 to 2030.

Clinical Trials 52

Clinical Trials Trials Treatment Clinical Research 52

The Pharma Data

NOVEMBER 19, 2020

Hyman currently serves as director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard and is the Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Previously, Baffa was Therapeutic Area Head of Oncology, Global Clinical Development for Shire. Affymetrix, Inc.,

Laboratories 52

Laboratories Research Laboratories Science Organic Chemistry 52

Drug Target Review

AUGUST 3, 2023

Engaging patient groups and recruiting participants for preclinical research studies remains a major challenge, as the necessary infrastructure for matchmaking and follow-up is still in its early stages. There are clinical trials underway for genetic subtypes of rare and common diseases. That needs to change.

DNA 52

DNA Clinical Trials Trials Disease 52

PPD

NOVEMBER 21, 2022

The medical communication experts at Thermo Fisher Scientific ’s PPD clinical research business were not satisfied with basic patient satisfaction data to inform our clients’ medical communication strategies. Are patients open to follow-up interactions from pharmaceutical companies?

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Pharmaceuticals Production 52

Conversations in Drug Development Trends

MAY 23, 2024

Accelerating Clinical Trials in the EU (ACT EU) ACT EU is an initiative designed to transform the initiation, development, and running of clinical trials within the EU. Master Protocols and Adaptive Trial Designs The increasing use of innovative trial designs like basket, umbrella, and platform trials is reshaping oncology research.

Trials 52

Trials Clinical Trials Therapies Treatment 52

The Pharma Data

JANUARY 17, 2021

The service is expected to become operational in 2021 and will be available for clinical research and clinical care — starting with private patients, followed by expansion into the public healthcare system over time. “We .–( BUSINESS WIRE )– Guardant Health, Inc. This press release features multimedia.

Clinical Trials 40

Clinical Trials FDA Approval Treatment Trials 40

The Pharma Data

MARCH 8, 2022

Johnson & Johnson supported the development of its vaccine with a truly global and inclusive clinical research program that studied the vaccine across the U.S., About the Janssen Pharmaceutical Companies of Johnson & Johnson At Janssen, we’re creating a future where disease is a thing of the past.

Vaccine 40

Vaccine Pharmaceutical Companies Pharmaceuticals Clinical Trials 40

The Pharma Data

OCTOBER 22, 2020

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world.

Clinical Trials 40

Clinical Trials Pharmaceutical Companies Clinical Development Pharmaceuticals 40

The Pharma Data

DECEMBER 15, 2020

SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. .” About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.SH)

Pharmaceuticals 40

Pharmaceuticals Clinical Trials Small Molecule Disease 40